These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 25163552)
1. Mitochondrial aldehyde dehydrogenase, a potential drug target for protection of heart and brain from ischemia/reperfusion injury. Luo XJ; Liu B; Ma QL; Peng J Curr Drug Targets; 2014; 15(10):948-55. PubMed ID: 25163552 [TBL] [Abstract][Full Text] [Related]
2. Alda-1 reduces cerebral ischemia/reperfusion injury in rat through clearance of reactive aldehydes. Fu SH; Zhang HF; Yang ZB; Li TB; Liu B; Lou Z; Ma QL; Luo XJ; Peng J Naunyn Schmiedebergs Arch Pharmacol; 2014 Jan; 387(1):87-94. PubMed ID: 24081521 [TBL] [Abstract][Full Text] [Related]
3. Alpha lipoic acid protects heart against myocardial ischemia-reperfusion injury through a mechanism involving aldehyde dehydrogenase 2 activation. He L; Liu B; Dai Z; Zhang HF; Zhang YS; Luo XJ; Ma QL; Peng J Eur J Pharmacol; 2012 Mar; 678(1-3):32-8. PubMed ID: 22266491 [TBL] [Abstract][Full Text] [Related]
4. Alda-1, an ALDH2 activator, protects against hepatic ischemia/reperfusion injury in rats via inhibition of oxidative stress. Zhang T; Zhao Q; Ye F; Huang CY; Chen WM; Huang WQ Free Radic Res; 2018 Jun; 52(6):629-638. PubMed ID: 29589772 [TBL] [Abstract][Full Text] [Related]
5. Poly(ADP-ribose) polymerase inhibition prevents reactive oxygen species induced inhibition of aldehyde dehydrogenase2 activity. Wei SJ; Xing JH; Wang BL; Xue L; Wang JL; Li R; Qin WD; Wang J; Wang XP; Zhang MX; Chen YG Biochim Biophys Acta; 2013 Mar; 1833(3):479-86. PubMed ID: 23159776 [TBL] [Abstract][Full Text] [Related]
6. Metabolic remodeling induced by mitochondrial aldehyde stress stimulates tolerance to oxidative stress in the heart. Endo J; Sano M; Katayama T; Hishiki T; Shinmura K; Morizane S; Matsuhashi T; Katsumata Y; Zhang Y; Ito H; Nagahata Y; Marchitti S; Nishimaki K; Wolf AM; Nakanishi H; Hattori F; Vasiliou V; Adachi T; Ohsawa I; Taguchi R; Hirabayashi Y; Ohta S; Suematsu M; Ogawa S; Fukuda K Circ Res; 2009 Nov; 105(11):1118-27. PubMed ID: 19815821 [TBL] [Abstract][Full Text] [Related]
7. Role of aldehyde dehydrogenase 2 in ischemia reperfusion injury: An update. Panisello-Roselló A; Lopez A; Folch-Puy E; Carbonell T; Rolo A; Palmeira C; Adam R; Net M; Roselló-Catafau J World J Gastroenterol; 2018 Jul; 24(27):2984-2994. PubMed ID: 30038465 [TBL] [Abstract][Full Text] [Related]
8. Aldehyde dehydrogenase-2 activation during cardioplegic arrest enhances the cardioprotection against myocardial ischemia-reperfusion injury. Gong D; Zhang Y; Zhang H; Gu H; Jiang Q; Hu S Cardiovasc Toxicol; 2012 Dec; 12(4):350-8. PubMed ID: 22814936 [TBL] [Abstract][Full Text] [Related]
9. Aldehydic load and aldehyde dehydrogenase 2 profile during the progression of post-myocardial infarction cardiomyopathy: benefits of Alda-1. Gomes KM; Bechara LR; Lima VM; Ribeiro MA; Campos JC; Dourado PM; Kowaltowski AJ; Mochly-Rosen D; Ferreira JC Int J Cardiol; 2015 Jan; 179():129-38. PubMed ID: 25464432 [TBL] [Abstract][Full Text] [Related]
10. Alda-1 Attenuates Lung Ischemia-Reperfusion Injury by Reducing 4-Hydroxy-2-Nonenal in Alveolar Epithelial Cells. Ding J; Zhang Q; Luo Q; Ying Y; Liu Y; Li Y; Wei W; Yan F; Zhang H Crit Care Med; 2016 Jul; 44(7):e544-52. PubMed ID: 26757166 [TBL] [Abstract][Full Text] [Related]
11. Pharmacological enrollment of aldehyde dehydrogenase modulators to assist treating ischemia reperfusion-induced intestinal injury: is there a gap to be bridged? Dollé L Clin Sci (Lond); 2017 Jun; 131(11):1137-1140. PubMed ID: 28533269 [TBL] [Abstract][Full Text] [Related]
12. Aldehyde dehydrogenase 2 (ALDH2) rescues myocardial ischaemia/reperfusion injury: role of autophagy paradox and toxic aldehyde. Ma H; Guo R; Yu L; Zhang Y; Ren J Eur Heart J; 2011 Apr; 32(8):1025-38. PubMed ID: 20705694 [TBL] [Abstract][Full Text] [Related]
13. Mitochondrial aldehyde dehydrogenase in myocardial ischemia-reperfusion injury: from bench to bedside. Pang JJ; Barton LA; Chen YG; Ren J Sheng Li Xue Bao; 2015 Dec; 67(6):535-44. PubMed ID: 26701629 [TBL] [Abstract][Full Text] [Related]
15. Piperlonguminine a new mitochondrial aldehyde dehydrogenase activator protects the heart from ischemia/reperfusion injury. Yoval-Sánchez B; Calleja LF; de la Luz Hernández-Esquivel M; Rodríguez-Zavala JS Biochim Biophys Acta Gen Subj; 2020 Nov; 1864(11):129684. PubMed ID: 32679250 [TBL] [Abstract][Full Text] [Related]
16. Mitochondrial aldehyde dehydrogenase-2 deficiency compromises therapeutic effect of ALDH bright cell on peripheral ischemia. Sun X; Zhu H; Dong Z; Liu X; Ma X; Han S; Lu F; Wang P; Qian S; Wang C; Shen C; Zhao X; Zou Y; Ge J; Sun A Redox Biol; 2017 Oct; 13():196-206. PubMed ID: 28582728 [TBL] [Abstract][Full Text] [Related]
17. Aldehyde dehydrogenase 2 in cardiac protection: a new therapeutic target? Budas GR; Disatnik MH; Mochly-Rosen D Trends Cardiovasc Med; 2009 Jul; 19(5):158-64. PubMed ID: 20005475 [TBL] [Abstract][Full Text] [Related]
18. Impaired cardiac SIRT1 activity by carbonyl stress contributes to aging-related ischemic intolerance. Gu C; Xing Y; Jiang L; Chen M; Xu M; Yin Y; Li C; Yang Z; Yu L; Ma H PLoS One; 2013; 8(9):e74050. PubMed ID: 24040162 [TBL] [Abstract][Full Text] [Related]
19. Mitochondrial Aldehyde Dehydrogenase in Myocardial Ischemic and Ischemia-Reperfusion Injury. Ding J; Yang Z; Ma H; Zhang H Adv Exp Med Biol; 2019; 1193():107-120. PubMed ID: 31368100 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of ALDH2 by O-GlcNAcylation contributes to the hyperglycemic exacerbation of myocardial ischemia/reperfusion injury. Liu B; Wang J; Li M; Yuan Q; Xue M; Xu F; Chen Y Oncotarget; 2017 Mar; 8(12):19413-19426. PubMed ID: 28038474 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]